Zoetis (ZTS) Has a Huge Animal Health Moat. Is It Starting to Crack?

What happened: Zoetis (ZTS) faces simultaneous competition across several of its largest franchises, with rivals using discounts, rebates, and bundled offers to win veterinarians and pet owners. Key numbers: Over 5,500 granted patents and 1,600 pending applications across more than 50 countries. Why it matters: Management said price has become more important in prescribing decisions, forcing targeted gross-to-net investments to defend volume and slow share losses, meaning Zoetis will sacrifice some realized price to protect its position.

Zoetis (ZTS) faces simultaneous competition across several of its largest franchises, with rivals using discounts, rebates, and bundled offers to win veterinarians and pet owners.

Management said price has become more important in prescribing decisions, forcing targeted gross-to-net investments to defend volume and slow share losses, meaning Zoetis will sacrifice some realized price to protect its position.